단백질 인산화의 정량화를 위한 최적화된 단일 분자 풀다운 분석

Executive Industry Relevance

Quantifying protein phosphorylation at the single-molecule level addresses a critical gap in understanding signaling heterogeneity and mechanistic pathway activation in drug discovery. The optimized SiMPull assay enables robust, quantitative assessment of receptor phosphorylation, supporting predictive confidence in target validation and early discovery decisions. This capability enhances portfolio triage by providing high-resolution data on posttranslational modifications relevant to disease biology.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables interrogation of phosphorylation status for individual membrane receptors, clarifying pathway activation.
• Supports biological de-risking by revealing heterogeneity in posttranslational modification across protein populations.
• Improves predictive confidence for target engagement and functional validation.

Screening & Assay Development

• Prepares validated, quantitative single-molecule readouts for downstream screening workflows.
• Standardizes assay conditions through optimized antibody labeling and fixation protocols.
• Facilitates reproducible, scalable quantification of phosphorylation for compound evaluation.

Translational & Preclinical Research

• Aligns phosphorylation measurements with disease-relevant signaling pathways for translational biomarker development.
• Provides continuity from discovery through preclinical validation by enabling mechanistic de-risking.
• Supports risk-adjusted advancement decisions based on quantitative modification data.

Pipeline & Workflow Integration

The SiMPull assay integrates into the discovery continuum from early target validation through lead identification and preclinical research, providing a reusable platform for quantitative posttranslational analysis.

• Discovery Biology: Supports hypothesis testing and pathway clarification by quantifying phosphorylation at the single-molecule level.
• Screening: Delivers reproducible, quantitative outputs for assay readiness and compound screening.
• Analytics: Provides robust statistical measurements of phosphorylation fractions across thousands of receptors.
• Translational Research: Enables alignment of signaling data with disease models for biomarker continuity.
• Enterprise Reuse: Offers a generalizable protocol adaptable to diverse membrane receptors and signaling proteins.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
• Operational Value: Enhances standardization, reproducibility, and scalability of phosphorylation assays.
• Strategic Value: Improves go/no-go decisions and capital efficiency by providing high-resolution modification data.
• Portfolio Impact: Enables risk-adjusted prioritization and advancement of discovery programs.

Implementation Considerations

• Requires expertise in single-molecule imaging and quantitative data analysis.
• Demands specialized instrumentation for fluorescence imaging and robust computational infrastructure.
• Necessitates cross-team standardization of antibody labeling and fixation protocols.
• Adaptable to various model systems with protocol optimization for different protein targets.
• Practical limitations include the need for high-quality reagents and careful control of autofluorescence.

Biopharma FAQs